Layth Saleh, MD
Clinical Cardiac Electrophysiology · Lakewood, CONPI 1427201938
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $11,821 of the $14,226 with a category attached, or 83.1%. It is spread thinly across 38 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $3,644 and has fallen 92.9% since, to $258 in 2025.
Across 377 payments — averaging $37.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Medtronic$2K
- Biosense Webster, Inc.$2K
- Boston Scientific$2K
- Medical Device Business Services, Inc.$2K
- Amgen$475
- plus $4K from 32 others
Across 5 payments — averaging $32,788 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cordis US CORP.$164K
What the payments were for
- Travel & lodging$2,03014%
- Food & beverage$11,82183%
- Education$1511%
- Other$2242%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 45 | $2,149 |
| Medtronic(3 entities) | 32 | $2,062 |
| Biosense Webster, Inc. | 64 | $1,955 |
| Boston Scientific | 55 | $1,802 |
| Medical Device Business Services, Inc. | 5 | $1,541 |
| Amgen | 20 | $475 |
| E.r. Squibb & Sons, L.L.C. | 23 | $464 |
| Johnson & Johnson | 12 | $351 |
| Impulse Dynamics (USA) Inc. | 7 | $350 |
| Novartis | 19 | $337 |
| Sanofi-aventis U.S. LLC | 15 | $293 |
| Atricure, Inc. | 4 | $265 |
| Baxter Healthcare | 3 | $252 |
| Cvrx, Inc. | 4 | $223 |
| Pfizer | 12 | $209 |
| Abiomed | 3 | $179 |
| Cardiovascular Systems Inc. | 2 | $135 |
| Merck | 8 | $127 |
| Boehringer Ingelheim | 7 | $126 |
| Cordis US CORP. | 1 | $125 |
| Astellas Pharma US Inc | 2 | $114 |
| Shockwave Medical, Inc | 1 | $98 |
| Bardy Diagnostics, Inc. | 5 | $83 |
| AstraZeneca | 4 | $67 |
| Alnylam Pharmaceuticals Inc. | 3 | $60 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $60 |
| Heartflow, Inc. | 2 | $56 |
| Kiniksa Pharmaceuticals, Ltd. | 3 | $49 |
| Amarin Pharma, Inc. | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 2 | $33 |
| Akcea Therapeutics, Inc. | 1 | $24 |
| Vifor Pharma, Inc. | 1 | $23 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $22 |
| Inogen, Inc. | 1 | $18 |
| Angiodynamics, Inc. | 1 | $18 |
| BD | 1 | $17 |
| Novo Nordisk | 1 | $15 |
| Tactile Systems Technology Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3 System$1,541
- Micra$754
- WATCHMAN Access System$490
- Carto 3$426
- OPTIMIZER$337
- Fortify Assura, Ellipse ICD$212
- SensiTherm (ICE)$184
- HawkOne$176
- Ensite Cardiac Mapping System$174
- LUX-Dx Insertable Cardiac Monitor$170
- Accent Pacemaker$164
- RESOLUTE ONYX$164
- Barostim Neo System$155
- ENSITE PRECISION$152
- Impella$149
- MYNX CONTROL$125
- Repatha$125
- Assurity Pacemaker$125
- ATRICLIP LAA EXCLUSION SYSTEM$123
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$123
How this compares
$14,226 in reported general payments places this provider in the 55th percentile of 66 clinical cardiac electrophysiology providers in Colorado.
See all clinical cardiac electrophysiology providers in Colorado →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 599 | $579,450 |
| XareltoRivaroxaban | 157 | $172,766 |
| EntrestoSacubitril/Valsartan | 38 | $39,487 |
| MultaqDronedarone Hcl | 24 | $19,687 |
| Metoprolol Succinate | 422 | $5,447 |
| Flecainide Acetate | 89 | $2,907 |
| Diltiazem 12hr ErDiltiazem Hcl | 15 | $2,120 |
| Diltiazem 24hr ErDiltiazem Hcl | 49 | $1,524 |
| Diltiazem 24hr Er (La)Diltiazem Hcl | 14 | $1,112 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 50 | $892 |
| Losartan Potassium | 92 | $788 |
| Metoprolol Tartrate | 131 | $760 |
| Atorvastatin Calcium | 110 | $735 |
| Sucralfate | 23 | $724 |
| Furosemide | 117 | $718 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $209 | $579,450599 claims |
| Johnson & JohnsonXarelto | $351 | $172,766157 claims |
| NovartisEntresto | $337 | $39,48738 claims |
| Sanofi-aventis U.S. LLCMultaq | $293 | $19,68724 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 66 clinical cardiac electrophysiology providers in Colorado.
Other clinical cardiac electrophysiology in Lakewood
- Ganesh VenkataramanLakewood$127K
- Srikanth SundaramLittleton$493K
- Bradley MikaelianColorado Springs$364K
- Wendy TzouAurora$350K
- Christopher PorterfieldAurora$340K
- Lohit GargAurora$147K
- Ethan EllisFort Collins$144K
- Margot VlokaAurora$104K
- Benjamin SteinbergDenver$98K
- Shu ChangColorado Springs$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.